cervical cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Group Level This study will include nine maternal and child health hospitals that perform colposcopy, consisting of six county-level maternal and child health hospitals in rural areas and three district-level maternal and child health hospitals in urban areas. The inclusion criteria are as follows: (1) The hospital is responsible for local cervical cancer screening and has the capability to perform colposcopy; (2) No other colposcopy training programs are planned during the study period; (3) Willingness to participate in this study. 2.Individual Level Inclusion criteria for individual participants: Women aged 35–64 who have not undergone cervical cancer screening in the past three years during the study period; Women referred for colposcopy due to abnormal cervical cancer screening results, specifically for any of the following reasons: Positive HPV test: Positive for HPV16 or HPV18, or persistent infection with other high-risk HPV subtypes; Abnormal cytology results: Cytology results showing abnormalities greater than atypical squamous cells of undetermined significance (ASC-US), or ASC-US with a positive HPV triage test; Positive visual inspection with acetic acid/Lugol’s iodine (VIA/VILI); Willingness to participate in the study.
Exclusion criteria
Exclusion criteria: Individual-Level Exclusion Criteria: Women with a history of cervical cancer or precancerous lesions; Women with a history of treatment for cervical cancer or precancerous lesions; Pregnant women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| colposcopy diagnostic accuracy; | — |
Secondary
| Measure | Time frame |
|---|---|
| The standardization rate of colposcopy reports;Trainee’s test score on the iDECO platform;Trainee satisfaction with the iDECO training; | — |
Countries
China
Contacts
Chinese Academy of Medical Sciences and Peking Union Medical College